Major Portfolio Changes at Berkshire Hathaway in First Quarter 2018

In its SEC Form 13F filed after the market closed today, Berkshire Hathaway revealed the following major portfolio changes that were not previously reported:

(1) Teva Pharmaceuticals (TEVA) – a $400 million or 115% increase in its stake.  (Likely purchase of Todd Combs or Ted Weschler)

(2) Monsanto (MON) – a $800 million or 62% increase in its stake.  (Note: Monsanto closed at $125.29 per share today and it is being acquired by Bayer at $128 per share.)